| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |